Central blood pressure is believed to provide a more accurate reflection of the pressure experienced by the internal organs,[sup.
Central blood pressure measurements and antihypertensive therapy: a consensus document.
While the brachial blood pressure was found to be similar in both African-American and white men, the Afro-Americans still scored higher in central blood pressure
Its technology allows researchers and clinicians to assess central blood pressure
Nasdaq: ENCO), an international full service contract research organization (CRO) that provides comprehensive clinical solutions for pharmaceutical, biotechnology and medical device companies, and AtCor Medical Holdings Limited (ASX:ACG), the developer and marketer of the SphygmoCor system which measures central blood pressures
non-invasively, today announced a joint marketing agreement for products and services that is anticipated to strengthen the fundamental value offerings of both companies.
Major clinical studies using SphygmoCor, such as the CAFE and strong Heart Studies, showed that high central blood pressure by itself was a predictor of cardiovascular events such as stroke or heart attack, and that traditional blood pressure measurement alone was not.
SphygmoCor can be a very valuable tool in assessing the risk posed by elevated central blood pressure and arterial hardening.
Central blood pressures differ from traditional cuff blood pressure measurements taken at the arm in many ways.
In the ASCOT and CAFE trials, central blood pressure measurements were necessary to adequately explain differences in outcomes between the drug regimens studied.
SphygmoCor enables, for the first time, non-invasive measurement of central blood pressures and other key heart function parameters.